Kevin Peterson's questions to Biostem Technologies Inc (BSEM) leadership • Q2 2024
Question
Kevin Peterson of Petersen Capital asked for an overview of the key drivers behind the rapid growth of AmnioWrap2 and the company's outlook for this trend.
Answer
Executive Jason Matuszewski attributed the growth to a successful partnership with Venture Medical, which has effectively communicated the value of the BioRetain technology. He highlighted the product's clinical success, validated by a published retrospective study, and a strategic focus on the mobile wound care setting, particularly on the West Coast, which has improved patient access and outcomes.